Custom Panel Service

About Aplex Bio

Aplex Bio is pioneering Hyperplex PCR (hpPCR), a quantitative endpoint PCR technology that combines padlock probes, rolling circle amplification (RCA), and proprietary Nanopixels™ to achieve unprecedented multiplexing (100+ targets/well), ultra-sensitivity (1 copy/reaction), and single-nucleotide specificity. The platform is designed to integrate seamlessly into standard lab workflows using existing equipment, offering an alternative to the high cost and complexity of NGS and the limited multiplexing of qPCR/dPCR. The company, based in Stockholm, is in the commercial stage for its assay kits, targeting the research tools and molecular diagnostics markets with a focus on applications requiring high-plex, precise genetic analysis.